News
As the administration pushes for a return to US manufacturing, outsourcing agreements with domestic manufacturers are ...
President Donald Trump put the biopharma industry on its back foot earlier this month with his executive order on ...
President Donald Trump signed an executive order Monday directing government health insurance agencies to purchase drugs at the lower prices that drugmakers charge in foreign countries. He said this ...
In a statement after the signing ceremony, Stephen Ubl, the CEO of trade group PhRMA ... are planning to invest in America—threatening jobs, hurting our economy and making us more reliant ...
JULIANA KAGWA is one of the most recognisable figures in Uganda’s marketing sector. Famed for her role in almost ...
Following President Donald Trump's most favored nation executive order, HHS and CMS have released the target price for ...
Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...
13d
Pharmaceutical Technology on MSNHHS sets “most favoured nation” pricing targets for drug makersThe US Department of Health and Human Services (HHS) said it is “taking immediate steps” to implement a recent Executive ...
What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or great.
Policy aims to drive drug companies to lower prices domestically while other countries shoulder more of the cost.
President Donald Trump signed a sweeping executive order Monday morning that promises to crack down on “unreasonable or ...
Ubl, the president of the Pharmaceutical Research ... member companies are planning to invest in America – threatening jobs, hurting our economy and making us more reliant on China for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results